EU Cross-Border Healthcare: What New Policies Mean for Patients Today

Introduction: Navigating Healthcare Across EU Borders

EU cross-border healthcare today rests on Directive 2011/24/EU, which guarantees every EU citizen the right to seek medical treatment in another member state and claim reimbursement from their home country's health system. Patients do not need special permission for most outpatient care, and reimbursement is calculated at the rate their home system would have paid domestically. What has changed in 2026 is not the legal foundation itself but the pressure building around it: a workforce mental health crisis and a stalled digital rollout are now shaping how well that right actually functions in practice.

For readers in Germany, France, the Netherlands, Spain, Italy, Belgium, Sweden and Poland, understanding this framework matters more than ever as waiting lists lengthen and staff shortages push more patients to look across the border for faster or specialised care. This article draws on the European Commission's own 2026 evaluation work and the latest World Health Organization data to explain what is really happening, and what it means for anyone considering treatment abroad.

Current Framework: Rights and Reimbursements for EU Patients

Under the Patients' Rights Directive, any EU national can travel to another member state for planned or unplanned care and be reimbursed up to the cost the treatment would have incurred at home, provided the care is on the list of reimbursable services in their home country. Reimbursement is not automatic for all procedures; hospital treatment may still require prior authorisation.

On 26 March 2026, the European Commission held the EU4Health closing conference on patients' rights and cross-border healthcare in Brussels, bringing together national contact points and patient organisations to assess how the Directive is working more than a decade after it came into force. The conference confirmed a persistent problem: many citizens remain unaware they have this right at all, and structural barriers, from language gaps to inconsistent national contact point resources, still limit uptake.

A central theme was rare diseases, which affect an estimated 40 million people across Europe. The European Reference Networks (ERNs), which pool specialist expertise across member states, were highlighted as the practical mechanism through which cross-border rights translate into real access for patients whose conditions cannot be adequately treated in their home country. The 2026 call for applications for Affiliated Partner status within the ERNs is now open, a sign the Commission wants to widen this network rather than let it stagnate.

Impact of the European Mental Health Crisis on Cross-Border Care

A workforce in crisis directly threatens the availability of the doctors and nurses who make cross-border referrals and treatment possible, regardless of what the law says patients are entitled to. This is the underreported angle behind the cross-border healthcare debate in 2026: patient rights on paper mean little if the workforce delivering care is buckling.

The Mental Health of Nurses and Doctors (MeND) survey, run by WHO/Europe with support from the European Commission, launched in October 2025 and gathered over 90,000 responses from health workers across the EU, Iceland and Norway. Its findings, published in 2026, are stark: one in three doctors and nurses report depression or anxiety, and one in ten report having had suicidal thoughts. Specifically, 28 to 32 percent report symptoms consistent with major depressive disorder and 24 percent report symptoms consistent with an anxiety disorder.

The knock-on effects are measurable. Among health workers with depressive symptoms, 40 percent took sick leave in the past year compared with 15 percent of those without symptoms, and 34 percent report an intention to leave their job compared with 17 percent of unaffected colleagues. One in three doctors and nurses also reported exposure to bullying or violent threats at work.

Dr Hans Henri P. Kluge, WHO Regional Director for Europe, did not mince words: "We simply cannot afford to lose them to burnout, despair or violence," he said, adding that "this is a health security crisis jeopardizing the functioning of our health systems." He described the situation bluntly: "Europe's health systems are under threat, and mental health is at the heart of the crisis."

The social impact of this crisis reaches well beyond hospital staff rooms. When health workers leave the profession or go on long-term sick leave, waiting lists grow fastest for people who cannot afford private alternatives, low-income households, older patients with chronic conditions, and rural communities already served by fewer clinicians. For patients weighing cross-border treatment, staff shortages at home are often the very reason they look abroad, yet the same shortages are appearing, to varying degrees, across most member states simultaneously. This is a shared European problem, not one country's staffing failure, and it makes the case for coordinated EU-level workforce policy rather than fragmented national fixes. Readers can find further context in Baba International's health articles, which track how workforce pressures are reshaping care access across the continent.

The Commission's June 2023 Communication on a comprehensive approach to mental health set out the ambition to place mental health on an equal footing with physical health across the EU. Three years on, the MeND data suggests the workforce underpinning that ambition is itself in urgent need of support, and the Commission used European Public Health Week, held from 4 to 8 May 2026 under the theme "Investing for sustainable health and well-being," to press member states on the point.

Digital Health Initiatives and Their Role in Patient Mobility

Digital infrastructure is meant to be the quiet enabler of cross-border care, letting a prescription or medical history follow a patient across a border as easily as they travel themselves. The European Health Data Space (EHDS) Regulation and its central platform, MyHealth@EU, are designed to do exactly that.

Some services are expected to go live during 2026, allowing a patient from one member state to walk into a pharmacy elsewhere in the EU with a digitally signed ePrescription issued at home, while a downloadable patient summary gives a foreign doctor instant access to allergies, chronic conditions and current medication. Austria has already amended its national law to enable participation. However, the full legal deadline for all 27 member states to exchange patient summaries and ePrescriptions via MyHealth@EU is not until March 2029, and the preparatory TEHDAS2 joint action, involving 29 countries, runs only until December 2026 to build the shared governance and infrastructure member states still need.

For patients today, this means digital continuity of care cannot yet be assumed everywhere. Anyone planning treatment abroad in 2026 should still expect to carry paper records or verify with their destination country's national contact point whether electronic exchange is actually operational for their specific route.

Future Outlook for EU Cross-Border Healthcare Policies

Expect policy attention over the next 12 to 24 months to concentrate on three fronts: raising patient awareness of existing rights, expanding the European Reference Networks for rare diseases, and closing the workforce mental health gap identified by the MeND survey. The Commission's own evaluation work, feeding into a possible revision of the 2011 Directive, is examining whether prior authorisation rules and reimbursement caps still serve patients well given today's staffing realities.

Mental health access itself is likely to become a cross-border issue in its own right. The Health at a Glance: Europe 2022 report found that almost one in two young Europeans (49 percent) reported unmet needs for mental health care, compared with 23 percent of the adult population, a gap that had been even wider at 53 percent in 2021. If national systems cannot close that gap alone, pressure will grow to make cross-border mental health referrals as routine as physical health ones already are.

Advice for EU Patients Considering Treatment Abroad

Patients considering care in another member state should take practical steps before travelling rather than assuming reimbursement is automatic.

• Contact your national contact point for cross-border healthcare before booking any treatment to confirm reimbursement eligibility and any prior authorisation requirements.
• Request a written cost estimate from the foreign provider and keep all invoices and medical reports for your reimbursement claim.
• Ask explicitly whether your destination country's MyHealth@EU services are active for ePrescriptions or patient summaries, since coverage still varies by country in 2026.
• Check whether the treatment is on your home country's reimbursable list, since coverage is capped at domestic rates, not the price charged abroad.
• For rare disease diagnoses, ask your specialist whether your case qualifies for referral through a European Reference Network.

Readers managing the financial side of cross-border care may also find it useful to review Baba International's finance coverage for guidance on EU health insurance and reimbursement planning.

Conclusion: Towards a More Integrated European Health System

The legal right to cross-border care in the EU is well established, but 2026 has exposed how much that right depends on a stable, mentally healthy workforce and digital infrastructure that is still years from completion. The MeND survey, the EU4Health conference outcomes, and the slow rollout of MyHealth@EU all point the same direction: patient mobility across EU borders will only become smoother once member states address staffing and digital gaps together, not in isolation. For now, informed patients who use their national contact points and understand the current limits of digital health exchange remain best placed to benefit from the rights they already have. Further analysis of EU health policy is available through Baba International.

Related Reading

• UK Mounjaro Rollout: How to Get the NHS Weight Loss Jab
• UK NHS AI Triage Tool: How Digital Solutions Reduce Phone Queues Today
• NHS Resident Doctors Strike: How Hospital Appointments and A&E Are Affected
• Europe's Digital Healthcare Transformation: How AI and Data Sharing are Reshaping Patient Care

Frequently Asked Questions

Can I get reimbursed for treatment in another EU country?

Yes. Under Directive 2011/24/EU, EU citizens can be reimbursed for healthcare received in another member state at the rate their home country would have paid, provided the treatment is on their home country's reimbursable list. Some hospital treatments require prior authorisation, so check with your national contact point first.

Is the EU mental health workforce crisis affecting cross-border care?

Indirectly, yes. The 2026 WHO/Europe MeND survey found one in three doctors and nurses across the EU report depression or anxiety, with 34 percent considering leaving the profession. Staff shortages linked to this crisis contribute to longer waiting times, which is one reason more patients are looking abroad for treatment.

What is MyHealth@EU and is it working in 2026?

MyHealth@EU is the EU's digital platform for exchanging ePrescriptions and patient summaries across borders. Some services are becoming operational in 2026, but full implementation across all 27 member states is not required until March 2029, so coverage still varies by country.

How does the European Reference Network help rare disease patients?

European Reference Networks connect specialists across member states to support the estimated 40 million people in Europe living with a rare disease, enabling referrals to expertise that may not exist in a patient's home country.